Amylyx Pharmaceuticals
AMLX
AMLX
178 hedge funds and large institutions have $929M invested in Amylyx Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 78 increasing their positions, 46 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $50.9M | Put options by funds: $50.4M
14% less capital invested
Capital invested by funds: $1.08B → $929M (-$150M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
178
Holding in Top 10
4
Calls
$50.9M
Puts
$50.4M
Top Buyers
| 1 | +$69.3M | |
| 2 | +$40.5M | |
| 3 | +$14.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.7M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$12.9M |
Top Sellers
| 1 | -$38.2M | |
| 2 | -$31.1M | |
| 3 | -$24.9M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$23.1M |
| 5 |
SC
Samlyn Capital
New York
|
-$21.3M |